The master antioxidant defense is activated during EBV latent infection
Journal of Virology · 2023
DOI: 10.1128/jvi.00953-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2023. Verfasst von Ling Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University , Johnson City, Tennessee, USA. Hauptthemen laut MEDLINE: Antioxidants, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Latent Infection. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, HHS | NIH | National Cancer Institute.
Abstract (Originalsprache)
Our recent publication shows for the first time that the master antioxidant pathway Keap1-NRF2 is constitutively activated in EBV- or HTLV1-transformed cells, with the mechanism being unclear (L. Wang, M. E. A. Howell, A. Sparks-Wallace, C. Hawkins, et al., PLoS Pathog 15:e1007541, 2019, https://doi.org/10.1371/journal.ppat.1007541 ). In this follow-up investigation, we show that EBV-triggered ROS production activates the Keap1-NRF2 pathway in EBV-transformed cells, and LMP1 plays a major role in this event. Further investigation shows that the mitochondria in cell lines with EBV Type 3 latency produce higher levels of mitochondrial ROS that are responsible for the activation of the Keap1-NRF2 pathway, compared with Type 1 latency. Moreover, using both pharmaceutical inhibitors and CRISPR-mediated gene editing, we show that the stress-related kinase TBK1 is required for NRF2 activation. As to the functional consequences, shRNA-mediated knockdown of NRF2 in EBV-transformed IB4 and HTLV1-transformed MT4 cells elevates endogenous reactive oxygen species levels, promotes DNA damage, downregulates cell proliferation, and promotes EBV reactivation. These findings, together with our previous report, disclose how EBV controls the intricate balance between oxidative stress and antioxidant defense, which greatly improve our understanding of EBV latency and pathogenesis and may be leveraged to opportunities toward the improvement of therapeutic outcomes in EBV-associated diseases. IMPORTANCE To our knowledge, this is the first report delineating the activation of the master antioxidant defense during EBV latency. We show that EBV-triggered reactive oxygen species production activates the Keap1-NRF2 pathway in EBV-transformed cells, and LMP1 plays a major role in this event, and the stress-related kinase TBK1 is required for NRF2 activation. Moreover, we show that the Keap1-NRF2 pathway is important for cell proliferation and EBV latency maintenance. Our findings disclose how EBV controls the balance between oxidative stress and antioxidant defense, which greatly improve our understanding of EBV latency and pathogenesis and may be leveraged to opportunities toward the improvement of therapeutic outcomes in EBV-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University , Johnson City, Tennessee, USA.
- Center of Excellence for Inflammation, Infectious Diseases and Immunity, Quillen College of Medicine, East Tennessee State University , Johnson City, Tennessee, USA.
- Hepatitis (HCV/HIV) Program, James H. Quillen VA Medical Center , Johnson City, Tennessee, USA.
ORCID-Profile: Ling Wang, Zhi Q Yao, Shunbin Ning
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- HHS | NIH | National Cancer Institute
- HHS | NIH | National Institute of Dental and Craniofacial Research
- DOD | USA | MEDCOM | CDMRP | DOD Peer Reviewed Cancer Research Program
Zitieren
APA
Wang, L., Howell, M. E. A., Hensley, C. R., Ning, K., Moorman, J. P., Yao, Z. Q., & Ning, S. (2023). The master antioxidant defense is activated during EBV latent infection. Journal of Virology. https://doi.org/10.1128/jvi.00953-23
Vancouver
Wang L, Howell MEA, Hensley CR, Ning K, Moorman JP, Yao ZQ, et al. The master antioxidant defense is activated during EBV latent infection. Journal of Virology. 2023. doi:10.1128/jvi.00953-23
BibTeX
@article{Wang2023,
author = {Wang, Ling and Howell, Mary E A and Hensley, Culton R and Ning, Katharine and Moorman, Jonathan P and Yao, Zhi Q and Ning, Shunbin},
title = {The master antioxidant defense is activated during EBV latent infection},
journal = {Journal of Virology},
year = {2023},
doi = {10.1128/jvi.00953-23}
}
EUVIMED